BR112012004587A2 - composto antibacteriano de hidroxifenila - Google Patents

composto antibacteriano de hidroxifenila

Info

Publication number
BR112012004587A2
BR112012004587A2 BR112012004587A BR112012004587A BR112012004587A2 BR 112012004587 A2 BR112012004587 A2 BR 112012004587A2 BR 112012004587 A BR112012004587 A BR 112012004587A BR 112012004587 A BR112012004587 A BR 112012004587A BR 112012004587 A2 BR112012004587 A2 BR 112012004587A2
Authority
BR
Brazil
Prior art keywords
hydroxyphenyl
antibacterial compound
antibacterial
compound
hydroxyphenyl antibacterial
Prior art date
Application number
BR112012004587A
Other languages
English (en)
Inventor
Alexis Denis
Fabien Faivre
Mayalen Oxoby
Vincent Gerusz
Yannick Bonvin
Original Assignee
Fab Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fab Pharma Sas filed Critical Fab Pharma Sas
Publication of BR112012004587A2 publication Critical patent/BR112012004587A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
BR112012004587A 2009-09-01 2009-11-11 composto antibacteriano de hidroxifenila BR112012004587A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23899509P 2009-09-01 2009-09-01
PCT/EP2009/064973 WO2011026529A1 (en) 2009-09-01 2009-11-11 Novel antibacterial hydroxyphenyl compound

Publications (1)

Publication Number Publication Date
BR112012004587A2 true BR112012004587A2 (pt) 2016-04-05

Family

ID=41647099

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004587A BR112012004587A2 (pt) 2009-09-01 2009-11-11 composto antibacteriano de hidroxifenila

Country Status (17)

Country Link
US (1) US9272985B2 (pt)
EP (1) EP2473480B1 (pt)
JP (1) JP5626737B2 (pt)
KR (1) KR20120128594A (pt)
CN (1) CN102648176B (pt)
AU (1) AU2009352134B2 (pt)
BR (1) BR112012004587A2 (pt)
CA (1) CA2770741A1 (pt)
DK (1) DK2473480T3 (pt)
ES (1) ES2588984T3 (pt)
HK (1) HK1173136A1 (pt)
IL (1) IL218388A (pt)
MX (1) MX2012002580A (pt)
NZ (1) NZ598074A (pt)
PL (1) PL2473480T3 (pt)
WO (1) WO2011026529A1 (pt)
ZA (1) ZA201200617B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845087A1 (en) 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof
ES2483120T3 (es) * 2009-10-20 2014-08-05 Fab Pharma Sas Nuevas acil-piperazinonas y su uso como productos farmacéuticos
WO2015028104A1 (en) * 2013-08-29 2015-03-05 Fab Pharma Sas Novel drug combination
AU2014314122A1 (en) * 2013-08-29 2016-04-21 Fab Pharma Sas Novel drug formulation
EP3233889B1 (en) 2014-12-16 2022-07-06 Shanghai MicuRx Pharmaceutical Co., Ltd. Antimicrobial polymyxins for treatment of bacterial infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391195A (en) 1963-12-04 1968-07-02 Monsanto Res Corp Fluorinated polyphenyl ethers
CH477165A (de) 1967-08-01 1969-08-31 Geigy Ag J R Verfahren zum antimikrobiellen Ausrüsten bzw. zum Schützen von Textilien gegen den Befall durch Mikroorganismen und eine Flotte bzw. ein Bad zur Durchführung dieses Verfahrens
GB1390616A (en) 1971-07-27 1975-04-16 Ciba Geigy Ag Antibacterial compositions
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
AU2052599A (en) 1997-12-12 1999-07-05 Ciba Specialty Chemicals Holding Inc. O-derivatives of halogenated diphenyl ether compounds
GB9827391D0 (en) 1998-12-11 1999-02-03 Fundation O N C F Aldose reductase inhibitors and pharmaceutical compositions
DE10015525A1 (de) 2000-03-30 2001-10-11 Deutsches Krebsforsch Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung
JP2006507219A (ja) 2002-04-18 2006-03-02 セルメッド オンコロジー(ユーエスエー), インコーポレイテッド ペプチド脱ホルミル化酵素活性化プロドラッグ
FR2839448A1 (fr) 2002-05-07 2003-11-14 Oreal Utilisation d'esters de triclosan, de piroctone et de tropolone dans une composition a liberation controlee
EP1585751A4 (en) 2002-11-14 2008-08-13 Celmed Oncology Usa Inc PEPTIDE DEFORMYLASE-ACTIVATED PRODRUGS
JP2008509983A (ja) 2004-08-18 2008-04-03 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター
US7687547B2 (en) 2004-08-23 2010-03-30 Research Foundation Of State University Of New York Diphenyl ether antimicrobial compounds
US20060211697A1 (en) * 2004-12-08 2006-09-21 Liren Huang 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
US20070054884A1 (en) 2005-08-31 2007-03-08 Emergent Product Development Gaithersburg Inc. 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
EP1845087A1 (en) 2006-04-14 2007-10-17 Mutabilis SA Hydroxyphenyl derivatives and biological applications thereof

Also Published As

Publication number Publication date
IL218388A (en) 2015-11-30
US20120232155A1 (en) 2012-09-13
IL218388A0 (en) 2012-04-30
JP2013503816A (ja) 2013-02-04
EP2473480A1 (en) 2012-07-11
HK1173136A1 (zh) 2013-05-10
PL2473480T3 (pl) 2017-02-28
KR20120128594A (ko) 2012-11-27
AU2009352134B2 (en) 2014-12-18
WO2011026529A1 (en) 2011-03-10
US9272985B2 (en) 2016-03-01
JP5626737B2 (ja) 2014-11-19
MX2012002580A (es) 2012-07-20
DK2473480T3 (en) 2016-09-05
CA2770741A1 (en) 2011-03-10
EP2473480B1 (en) 2016-06-01
ZA201200617B (en) 2013-02-27
CN102648176B (zh) 2014-10-01
AU2009352134A1 (en) 2012-03-01
CN102648176A (zh) 2012-08-22
ES2588984T3 (es) 2016-11-08
NZ598074A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
CY2017026I1 (el) Τετρακυκλικη ενωση
SMT201500117B (it) Composti antibatterici
SMT201600008B (it) Composti di piridazinone
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
BRPI1005525A2 (pt) compostos de azaazuleno
BRPI1015203A2 (pt) agentes antimicrobianos
BR112012006859A2 (pt) compostos
BRPI1013868A2 (pt) composto diaciletilenodiamina
DK2427449T3 (da) Vinylindazolylforbindelser
BRPI1008774A2 (pt) espiroamida substituída
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
BRPI1010997A2 (pt) polímeros antimicrobianos
BRPI1009287A2 (pt) composto de quinoxalina
BRPI1013493A2 (pt) composto de pirimidina
BR112012002609A8 (pt) composição antimicrobiana sinergística
FR2947857B1 (fr) Agencement de deshuileur
GB0909030D0 (en) Antibacterial composition
BRPI0911393A2 (pt) composto de 5-hidroxipirimidina-4-carboxamida
ES1069911Y (es) Guia de brocas
HK1173136A1 (zh) 新的抗菌的羥基苯基化合物
BRPI0909461A2 (pt) Composto de enaminotiocarbonila substituídos
BR112012004643A2 (pt) compostos antibióticos
BRPI1007893A2 (pt) derivado de cianopirimidina
BRPI0906517A2 (pt) composições antibacterianas
BRPI1009199A2 (pt) compostos de pirazinoisoquinolina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]